The US Supreme Court’s decision in Caraco vs. Novo Nordisk clarifies the rights of generic drug manufacturers to challenge overly broad patent claims. This case marks a significant development for generic competition and FDA approval processes.
Read more about A Patently Generic WinTag: fda approval
Patent Term Extension, Dog ate my Homework Act
This post evaluates the impact of the proposed Dog ate my Homework Act on patent term extension deadlines at the USPTO. It focuses on deadline miscalculations in pharmaceutical patents and the possible benefits and fairness of a grace period for missed PTE requests.
Read more about Patent Term Extension, Dog ate my Homework Act